 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
23 News |  |
- MIN-117 / Minerva Neurosciences
Tolerability and safety of high-intensity continuous and intermittent exercise in COVID-19 (8N) - Jun 22, 2022 - Abstract #ERS2022ERS_4184;
Individuals with ongoing symptomatic COVID-19 could safely undertake high intensity exercise performed continuously or intermittently.
- | MIN-117 / Minerva Neurosciences
Retrospective data, Journal: Late umbilical cord clamping does not increase rates of jaundice and the need for phototherapy in pregnancies at normal risk. (Pubmed Central) - Jan 23, 2020
The clamping time of the umbilical cord showed no association with jaundice, bilirubin dosage, or phototherapy needs in neonates at normal risk. The adoption of late clamping was more prevalent in vaginal deliveries.
- |||| MIN-117 / Minerva Neurosciences
Trial completion: A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder (clinicaltrials.gov) - Jan 21, 2020
P2, N=360, Completed, Sponsor: Minerva Neurosciences
The adoption of late clamping was more prevalent in vaginal deliveries. Recruiting --> Completed
- | MIN-117 / Minerva Neurosciences
Trial completion date, Trial primary completion date: A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder (clinicaltrials.gov) - Aug 20, 2019
P2, N=324, Recruiting, Sponsor: Minerva Neurosciences
Recruiting --> Completed Trial completion date: Sep 2019 --> Dec 2019 | Trial primary completion date: Apr 2019 --> Dec 2019
- |||| MIN-117 / Minerva Neurosciences
Enrollment open: A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder (clinicaltrials.gov) - Sep 28, 2018
P2, N=324, Recruiting, Sponsor: Minerva Neurosciences
Trial completion date: Sep 2019 --> Dec 2019 | Trial primary completion date: Apr 2019 --> Dec 2019 Not yet recruiting --> Recruiting
- ||||| MIN-117 / Minerva Neurosciences
New P2 trial: A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder (clinicaltrials.gov) - Feb 27, 2018
P2, N=324, Not yet recruiting, Sponsor: Minerva Neurosciences